202 filings
Page 7 of 11
8-K
d31bv45j ia8rkyr7du
12 Mar 20
Evofem Biosciences Reports Fourth Quarter and Year-end 2019
8:00am
8-K
7nfnm 5xez
26 Feb 20
Evofem Biosciences Appoints Former FDA Division Director Lisa Rarick, M.D., to its Board of Directors
8:30am
8-K
5i9 onc07fxx5bty78ns
10 Jan 20
Regulation FD Disclosure
4:06pm
8-K
8mt4ndltb
16 Dec 19
Departure of Directors or Certain Officers
4:35pm
8-K
et6lf mziheft1
2 Dec 19
Other Events
6:50am
8-K
1ubzkinl
26 Nov 19
Other Events
7:30am
8-K
gezb9n8u
6 Nov 19
Evofem Biosciences Reports Third Quarter 2019
4:06pm
8-K
va9d305geitpqzmc
11 Oct 19
Entry into a Material Definitive Agreement
4:29pm
8-K
cllqs0wrs6ra5ffqwix
4 Sep 19
Regulation FD Disclosure
9:07am
8-K
0q4mu qrw
5 Aug 19
Evofem Biosciences Reports Second Quarter 2019
4:11pm
8-K
yjw41m0x
10 Jun 19
Evofem Biosciences Closes $80 Million Financing Transaction
4:01pm
8-K
wabtlv6 k1ho5
5 Jun 19
Departure of Directors or Certain Officers
5:07pm
8-K
mxf9kdiz
7 May 19
Evofem Biosciences Reports First Quarter 2019
6:13am
8-K
t5qa0nkn
11 Apr 19
Closes First Tranche of Strategic Investment from PDL BioPharma
5:16pm
8-K
vesqr
1 Mar 19
Evofem Biosciences Reports Fourth Quarter and Year-End 2018
12:00am
8-K
e0lczuemqb 66mo1
11 Feb 19
Entry into a Material Definitive Agreement
4:12pm
8-K
txfg8d23u9
7 Jan 19
Regulation FD Disclosure
6:11am
8-K
gkw 7lwh2
3 Jan 19
Evofem Biosciences Provides Corporate Update and Announces Upcoming Milestones
8:00am
8-K
1bs5j
17 Dec 18
Evofem Biosciences Announces Positive Top-Line Results of Phase 3 Study
6:05am
8-K
zp3ftl7c6463wlmo9v
7 Nov 18
Evofem Biosciences Reports Third Quarter 2018 Financial Results and Provides Corporate Update
6:51am